{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:18:20Z","timestamp":1792099100865,"version":"4.4.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jaad.2017.10.006","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T03:39:17Z","timestamp":1515555557000},"page":"540-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":408,"title":["Guidelines of care for the management of basal cell carcinoma"],"prefix":"10.1016","volume":"78","author":[{"given":"Christopher","family":"Bichakjian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy S.","family":"Bordeaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus J.","family":"Busam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Lober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliot","family":"Mostow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christen","family":"Mowad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishwer","family":"Nehal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Schmitt-Burr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Sekulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Storrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegrid","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conway","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Smith","family":"Begolka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y.S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Kozlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Olencki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.10.006_bib1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaad.2017.10.007","article-title":"Guidelines of care for the management of squamous cell carcinoma","volume":"78","author":"Alam","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.006_bib2","unstructured":"National Comprehensive Cancer Center. NCCN Clinical practice guidelines in oncology; basal cell skin cancer. Available at: www.nccn.org. Accessed April 1, 2015."},{"key":"10.1016\/j.jaad.2017.10.006_bib3","unstructured":"National Comprehensive Cancer Center. NCCN clinical practice guidelines in oncology; basal cell carcinoma (V1.2017). Available at: www.nccn.org. Accessed October 3, 2016."},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.2008.08666.x","article-title":"British Association of Dermatology. Guidelines for the management of basal cell carcinoma","volume":"159","author":"Telfer","year":"2008","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3122\/jabfm.17.1.59","article-title":"Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature","volume":"17","author":"Ebell","year":"2004","journal-title":"J Am Board Fam Pract"},{"key":"10.1016\/j.jaad.2017.10.006_bib6","unstructured":"American Academy of Dermatology. Administrative regulations; evidence based clinical practice guidelines. Available at: www.aad.org\/Forms\/Policies\/Uploads\/AR\/AR%20-%20Evidence-Based%20Clinical%20Guideline.pdf. Accessed December 1, 2014."},{"issue":"10","key":"10.1016\/j.jaad.2017.10.006_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2017.10.006_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.2014.9655","article-title":"Potential overdiagnosis of basal cell carcinoma in older patients with limited life expectancy","volume":"312","author":"Linos","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jaad.2015.04.005","article-title":"Counterpoint: limited life expectancy, basal cell carcinoma, health care today, and unintended consequences","volume":"73","author":"Fosko","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.006_bib10","series-title":"AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual","author":"Edge","year":"2010"},{"issue":"7","key":"10.1016\/j.jaad.2017.10.006_bib11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1468-3083.2012.04608.x","article-title":"Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma","volume":"27","author":"Roozeboom","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2011.02.042","article-title":"Accuracy of biopsy sampling for subtyping basal cell carcinoma","volume":"66","author":"Haws","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaad.2010.06.001","article-title":"Correlation between histologic findings on punch biopsy specimens and subsequent excision specimens in recurrent basal cell carcinoma","volume":"64","author":"Mosterd","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2133.2008.08829.x","article-title":"Shave biopsy without local anaesthetic to diagnose basal cell carcinoma and other skin tumours prior to definitive treatment: analysis of 109 lesions","volume":"160","author":"Smith","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0190-9622(99)70409-3","article-title":"Basal cell carcinoma: a comparison of shave biopsy versus punch biopsy techniques in subtype diagnosis","volume":"41","author":"Russell","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bjd.14458","article-title":"Is a punch biopsy reliable in subtyping basal cell carcinoma? A systematic review","volume":"175","author":"Kadouch","year":"2016","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/2000656X.2013.800526","article-title":"Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management","volume":"48","author":"Codazzi","year":"2014","journal-title":"J Plast Surg Hand Surg"},{"issue":"8","key":"10.1016\/j.jaad.2017.10.006_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1054\/bjps.2002.3948","article-title":"Incomplete excision of basal cell carcinoma: a prospective multicentre audit","volume":"55","author":"Kumar","year":"2002","journal-title":"Br J Plast Surg"},{"issue":"10","key":"10.1016\/j.jaad.2017.10.006_bib19","first-page":"1207","article-title":"Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases","volume":"33","author":"Farhi","year":"2007","journal-title":"Dermatol Surg"},{"issue":"11","key":"10.1016\/j.jaad.2017.10.006_bib20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archdermatol.2009.270","article-title":"Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners","volume":"145","author":"Hansen","year":"2009","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib21","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.3747\/co.21.1727","article-title":"Predictors of recurrence after radiotherapy for non-melanoma skin cancer","volume":"21","author":"Khan","year":"2014","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1524-4725.1992.tb03307.x","article-title":"Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision","volume":"18","author":"Silverman","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"issue":"7","key":"10.1016\/j.jaad.2017.10.006_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1524-4725.1992.tb03508.x","article-title":"Recurrence rates of treated basal cell carcinomas. Part 4: x-ray therapy","volume":"18","author":"Silverman","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"issue":"9","key":"10.1016\/j.jaad.2017.10.006_bib24","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1524-4725.1991.tb03425.x","article-title":"Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation","volume":"17","author":"Silverman","year":"1991","journal-title":"J Dermatol Surg Oncol"},{"issue":"1192","key":"10.1016\/j.jaad.2017.10.006_bib25","first-page":"U848","article-title":"Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty","volume":"117","author":"Talbot","year":"2004","journal-title":"N Z Med J"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0560.2009.01340.x","article-title":"Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer","volume":"37","author":"Rieger","year":"2010","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/TP.0b013e3181ec7228","article-title":"Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients","volume":"90","author":"Lott","year":"2010","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaad.2012.06.009","volume":"67","author":"Connolly","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2017.10.006_bib29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/DSS.0000000000000783","article-title":"Scalp basal cell carcinoma: review of 2,202 cases","volume":"42","author":"Cho","year":"2016","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0007-1226(93)90150-A","article-title":"Perineural infiltration in basal cell carcinomas","volume":"46","author":"Niazi","year":"1993","journal-title":"Br J Plast Surg"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.jid.5700740","article-title":"Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma","volume":"127","author":"Chren","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"17","key":"10.1016\/j.jaad.2017.10.006_bib32","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ejca.2014.08.018","article-title":"Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up","volume":"50","author":"van Loo","year":"2014","journal-title":"Eur J Cancer"},{"issue":"9447","key":"10.1016\/j.jaad.2017.10.006_bib33","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(04)17399-6","article-title":"Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial","volume":"364","author":"Smeets","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/bjc.1997.343","article-title":"Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study","volume":"76","author":"Avril","year":"1997","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.jaad.2017.10.006_bib35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archderm.143.9.1131","article-title":"Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma","volume":"143","author":"Rhodes","year":"2007","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.10.006_bib36","first-page":"579","article-title":"Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma","volume":"33","author":"Kuijpers","year":"2007","journal-title":"Dermatol Surg"},{"issue":"11","key":"10.1016\/j.jaad.2017.10.006_bib37","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1468-3083.2008.02803.x","article-title":"A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up","volume":"22","author":"Szeimies","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2013.02.014","article-title":"Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up","volume":"69","author":"Roozeboom","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","article-title":"Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial","volume":"15","author":"Bath-Hextall","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib40","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/PRS.0b013e3181ea450d","article-title":"What is the best surgical margin for a basal cell carcinoma: a meta-analysis of the literature","volume":"126","author":"Gulleth","year":"2010","journal-title":"Plast Reconstr Surg"},{"issue":"8","key":"10.1016\/j.jaad.2017.10.006_bib41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1524-4725.2000.ds00064.x","article-title":"Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck","volume":"26","author":"Thissen","year":"2000","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2017.10.006_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-4725.1989.tb03166.x","article-title":"Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up","volume":"15","author":"Rowe","year":"1989","journal-title":"J Dermatol Surg Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1524-4725.1989.tb03249.x","article-title":"Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma","volume":"15","author":"Rowe","year":"1989","journal-title":"J Dermatol Surg Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2006.07.007","article-title":"Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation","volume":"56","author":"Rodriguez-Vigil","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00042728-200601000-00011","article-title":"Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma","volume":"32","author":"Spencer","year":"2006","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib46","first-page":"CD003412","article-title":"Interventions for basal cell carcinoma of the skin","author":"Bath-Hextall","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib47","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-2133.2008.08787.x","article-title":"Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial","volume":"159","author":"Mosterd","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib48","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1097\/SCS.0b013e3181bd7533","article-title":"Is it really necessary to make wide excisions for basal cell carcinoma treatment?","volume":"20","author":"Unlu","year":"2009","journal-title":"J Craniofac Surg"},{"issue":"12","key":"10.1016\/j.jaad.2017.10.006_bib49","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(08)70260-2","article-title":"Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up","volume":"9","author":"Mosterd","year":"2008","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.jaad.2017.10.006_bib50","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1524-4725.2009.01240.x","article-title":"Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome","volume":"35","author":"Muller","year":"2009","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archsurg.1941.01210080079004","article-title":"Chemosurgery: a microscopically controlled method of cancer excision","volume":"42","author":"Mohs","year":"1941","journal-title":"Arch Surg"},{"key":"10.1016\/j.jaad.2017.10.006_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archsurg.1946.01230060334005","article-title":"Chemosurgical treatment of cancer of the nose; a microscopically controlled method","volume":"53","author":"Mohs","year":"1946","journal-title":"Arch Surg"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archderm.1974.01630080033008","article-title":"Microscopically controlled excision of skin tumors","volume":"110","author":"Tromovitch","year":"1974","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib54","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/1097-0142(197802)41:2<653::AID-CNCR2820410232>3.0.CO;2-X","article-title":"Microscopie-controlled excision of cutaneous tumors: chemosurgery, fresh tissue technique","volume":"41","author":"Tromovitch","year":"1978","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jaad.2017.10.006_bib55","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1524-4725.2012.02570.x","article-title":"Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers","volume":"38","author":"Ebede","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2017.10.006_bib56","series-title":"Appropriate uses of paraffin sections in association with Mohs micrographic surgery","year":"2014"},{"key":"10.1016\/j.jaad.2017.10.006_bib57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archderm.1960.01580020039006","article-title":"Curettage and electrodesiccation in the treatment of skin cancer","volume":"82","author":"Knox","year":"1960","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib58","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0190-9622(83)70055-1","article-title":"Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma","volume":"8","author":"Salasche","year":"1983","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.10.006_bib59","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0733-8635(02)00022-0","article-title":"The current status of curettage and electrodesiccation","volume":"20","author":"Goldman","year":"2002","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.jaad.2017.10.006_bib60","first-page":"547","article-title":"Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial","volume":"18","author":"Basset-Seguin","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib61","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2133.2001.04141.x","article-title":"Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial","volume":"144","author":"Wang","year":"2001","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0009-9260(86)80161-1","article-title":"Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy","volume":"37","author":"Hall","year":"1986","journal-title":"Clin Radiol"},{"issue":"10","key":"10.1016\/j.jaad.2017.10.006_bib63","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1524-4725.1996.tb00588.x","article-title":"Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules","volume":"22","author":"Mallon","year":"1996","journal-title":"Dermatol Surg"},{"issue":"7","key":"10.1016\/j.jaad.2017.10.006_bib64","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib65","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/09546630701557965","article-title":"A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma","volume":"19","author":"Ezughah","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib66","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaad.2007.05.022","article-title":"A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma","volume":"57","author":"Eigentler","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.10.006_bib67","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2133.2005.06486.x","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe","volume":"152","author":"Schulze","year":"2005","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.10.006_bib68","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies","volume":"50","author":"Geisse","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.10.006_bib69","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1067\/mjd.2002.126215","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study","volume":"47","author":"Geisse","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib70","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1365-2133.2002.05069.x","article-title":"Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion","volume":"147","author":"Sterry","year":"2002","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.10.006_bib71","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1067\/mjd.2001.113689","article-title":"Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial","volume":"44","author":"Marks","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.10.006_bib72","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archderm.138.9.1165","article-title":"Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens","volume":"138","author":"Shumack","year":"2002","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib73","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0190-9622(99)70261-6","article-title":"Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream","volume":"41","author":"Beutner","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib74","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2133.2012.11061.x","article-title":"Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials","volume":"167","author":"Roozeboom","year":"2012","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2017.10.006_bib75","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/archdermatol.2009.291","article-title":"Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review","volume":"145","author":"Love","year":"2009","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2017.10.006_bib76","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jid.2016.03.043","article-title":"Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial","volume":"136","author":"Roozeboom","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2017.10.006_bib77","first-page":"642","article-title":"Similar\u00a0effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma","volume":"5","author":"Kuijpers","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib78","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1524-4725.2000.99227.x","article-title":"A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier","volume":"26","author":"Romagosa","year":"2000","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib79","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0190-9622(97)70328-1","article-title":"Nonsurgical treatment\u00a0of basal cell carcinomas with intralesional 5-fluorouracil\/epinephrine injectable gel","volume":"36","author":"Miller","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib80","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1562\/0031-8655(2000)071<0724:PTOSBC>2.0.CO;2","article-title":"Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources","volume":"71","author":"Soler","year":"2000","journal-title":"Photochem Photobiol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib81","doi-asserted-by":"crossref","first-page":"PI5","DOI":"10.12659\/MSM.882449","article-title":"The application of Levulan-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma","volume":"18","author":"Osiecka","year":"2012","journal-title":"Med Sci Monit"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2340\/00015555-1448","article-title":"Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial","volume":"92","author":"de Vijlder","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2017.10.006_bib83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pdpdt.2007.04.004","article-title":"Comparison of aminolevulinic acid (ALA)-thermogel-PDT with methyl-ALA-thermogel-PDT in basal cell carcinoma","volume":"4","author":"Schleier","year":"2007","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2133.2009.09492.x","article-title":"Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study","volume":"162","author":"Apalla","year":"2010","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib85","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib86","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/phpp.12148","article-title":"Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis","volume":"31","author":"Wang","year":"2015","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"11","key":"10.1016\/j.jaad.2017.10.006_bib87","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-4632.2008.04022.x","article-title":"Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies","volume":"48","author":"Foley","year":"2009","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2017.10.006_bib88","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/1097-0142(19900501)63:9<1863::AID-CNCR2820630934>3.0.CO;2-4","article-title":"Treatment of nonmelanoma skin cancer at a large Australian center","volume":"63","author":"Ashby","year":"1989","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib89","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaad.2012.06.001","article-title":"Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients","volume":"67","author":"Cognetta","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib90","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.brachy.2012.08.003","article-title":"Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year","volume":"12","author":"Bhatnagar","year":"2013","journal-title":"Brachytherapy"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib91","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/j.prro.2015.07.002","article-title":"Clinical and cosmetic outcomes in patients treated with high-dose-rate electronic brachytherapy for nonmelanoma skin cancer","volume":"5","author":"Paravati","year":"2015","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5114\/jcb.2016.57531","article-title":"Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses","volume":"8","author":"Ballester-Sanchez","year":"2016","journal-title":"J Contemp Brachytherapy"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib93","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/lsm.20606","article-title":"Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma","volume":"40","author":"Smucler","year":"2008","journal-title":"Lasers Surg Med"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib94","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/lsm.22032","article-title":"Single treatment of non-melanoma skin cancers using a pulsed-dye laser with stacked pulses","volume":"44","author":"Tran","year":"2012","journal-title":"Lasers Surg Med"},{"issue":"7","key":"10.1016\/j.jaad.2017.10.006_bib95","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00403-010-1041-8","article-title":"Pharmacokinetics of imiquimod 3.75% cream applied daily for 3 weeks to actinic keratoses on the face and\/or balding scalp","volume":"302","author":"Kulp","year":"2010","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib96","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13555-015-0088-z","article-title":"Imiquimod 5% as adjuvant therapy for incompletely excised iInfiltrative nodular basal cell carcinoma and dermoscopy to monitor treatment response","volume":"5","author":"Roldan-Marin","year":"2015","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/01676830.2014.950296","article-title":"Imiquimod 5% cream as an adjuvant pre-operative treatment for basal cell carcinoma of the periocular area","volume":"33","author":"Bonilla","year":"2014","journal-title":"Orbit"},{"issue":"5","key":"10.1016\/j.jaad.2017.10.006_bib98","first-page":"461","article-title":"Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases","volume":"5","author":"Thissen","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib99","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2133.2007.07996.x","article-title":"A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma","volume":"157","author":"Berroeta","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.006_bib100","unstructured":"American Academy of Dermatology. Position statement on superficial radiation therapy for basal cell carcinoma (BCC) and squamous cell carcinomas (SCC). Available at: https:\/\/www.aad.org\/Forms\/Policies\/Uploads\/PS\/PS-Superficial%20Radiation%20Therapy.pdf. Accessed November 5, 2016."},{"key":"10.1016\/j.jaad.2017.10.006_bib101","unstructured":"American Academy of Dermatology. Position statement on electronic surface brachytherapy for basal cell carcinoma (BCC) and squamous cell carcinomas (SCC). Available at: https:\/\/www.aad.org\/Forms\/Policies\/Uploads\/PS\/PS%20-%20Electronic%20Surface%20Brachytherapy.pdf. Accessed November 5, 2016."},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib102","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archderm.1977.01640060079009","article-title":"Treatment of morphea-type basal cell carcinomas with radiation therapy","volume":"113","author":"Bart","year":"1977","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2017.10.006_bib103","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1754-9485.2012.02466.x","article-title":"HDR brachytherapy for superficial non-melanoma skin cancers","volume":"57","author":"Gauden","year":"2013","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2017.10.006_bib104","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jdv.13453","article-title":"Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial","volume":"30","author":"Choi","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib105","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0190-9622(84)80334-5","article-title":"Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature","volume":"10","author":"von Domarus","year":"1984","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib106","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3109\/02841869609083998","article-title":"Platinum-based cytotoxic therapy in basal cell carcinoma\u2014a review of the literature","volume":"35","author":"Moeholt","year":"1996","journal-title":"Acta Oncol"},{"issue":"23","key":"10.1016\/j.jaad.2017.10.006_bib107","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib108","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaad.2015.03.021","article-title":"Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC","volume":"72","author":"Sekulic","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib109","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1470-2045(15)70198-1","article-title":"Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial","volume":"16","author":"Basset-Seguin","year":"2015","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib110","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","article-title":"Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial","volume":"16","author":"Migden","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib111","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2016.02.1226","article-title":"The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): a phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma","volume":"75","author":"Dummer","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib112","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/1078-0432.CCR-15-1588","article-title":"An Investigator-initiated open-label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib","volume":"22","author":"Danial","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib113","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2013.09.012","article-title":"Expanded access study of patients with advanced basal cell carcinoma treated with the hedgehog pathway inhibitor, vismodegib","volume":"70","author":"Chang","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2017.10.006_bib114","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/jamadermatol.2016.0780","article-title":"Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies","volume":"152","author":"Jacobsen","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"23","key":"10.1016\/j.jaad.2017.10.006_bib115","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1113538","article-title":"Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome","volume":"366","author":"Tang","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2017.10.006_bib116","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/1055-9965.EPI-10-0243","article-title":"Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review","volume":"19","author":"Wheless","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib117","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jamadermatol.2014.3307","article-title":"Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma","volume":"151","author":"Wehner","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib118","doi-asserted-by":"crossref","first-page":"e1001433","DOI":"10.1371\/journal.pmed.1001433","article-title":"Risk of a second primary cancer after non-melanoma skin cancer in white men and women: a prospective cohort study","volume":"10","author":"Song","year":"2013","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib119","doi-asserted-by":"crossref","first-page":"e99674","DOI":"10.1371\/journal.pone.0099674","article-title":"Non melanoma skin cancer and subsequent cancer risk","volume":"9","author":"Rees","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jaad.2017.10.006_bib120","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamadermatol.2016.1985","article-title":"Early detection of new melanomas by patients with melanoma and their partners using a structured skin self-examination skills training intervention: a randomized clinical trial","volume":"152","author":"Robinson","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2017.10.006_bib121","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1158\/1055-9965.EPI-06-0352","article-title":"Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use","volume":"15","author":"van der Pols","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9180","key":"10.1016\/j.jaad.2017.10.006_bib122","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(98)12168-2","article-title":"Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial","volume":"354","author":"Green","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jaad.2017.10.006_bib123","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2017.10.006_bib124","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1940-6207.CAPR-13-0305","article-title":"Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome","volume":"7","author":"Tang","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/archdermatol.2008.542","article-title":"Topical tretinoin therapy and all-cause mortality","volume":"145","author":"Weinstock","year":"2009","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2017.10.006_bib126","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/84.5.328","article-title":"Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group","volume":"84","author":"Tangrea","year":"1992","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.jaad.2017.10.006_bib127","first-page":"957","article-title":"Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group","volume":"6","author":"Levine","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"10.1016\/j.jaad.2017.10.006_bib128","first-page":"949","article-title":"Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group","volume":"6","author":"Moon","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.jaad.2017.10.006_bib129","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/cncr.26374","article-title":"Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)","volume":"118","author":"Kadakia","year":"2012","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.jaad.2017.10.006_bib130","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jaad.2017.10.006_bib131","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1940-6207.CAPR-12-0233","article-title":"A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity","volume":"5","author":"Kreul","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib132","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/1940-6207.CAPR-09-0096","article-title":"A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer","volume":"3","author":"Bailey","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"24","key":"10.1016\/j.jaad.2017.10.006_bib133","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/jnci\/djq442","article-title":"Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial","volume":"102","author":"Elmets","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.jaad.2017.10.006_bib134","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1940-6207.CAPR-09-0200","article-title":"Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+\/- humans and mice","volume":"3","author":"Tang","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"issue":"24","key":"10.1016\/j.jaad.2017.10.006_bib135","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1001\/jama.1996.03540240035027","article-title":"Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group","volume":"276","author":"Clark","year":"1996","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.jaad.2017.10.006_bib136","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/jnci\/djg061","article-title":"Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial","volume":"95","author":"Duffield-Lillico","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.jaad.2017.10.006_bib137","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJM199009203231204","article-title":"A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group","volume":"323","author":"Greenberg","year":"1990","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jaad.2017.10.006_bib138","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/djn260","article-title":"Nonmelanoma skin cancer and risk for subsequent malignancy","volume":"100","author":"Chen","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.jaad.2017.10.006_bib139","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archderm.136.12.1524","article-title":"Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis","volume":"136","author":"Marcil","year":"2000","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2017.10.006_bib140","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ejca.2013.03.010","article-title":"Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis","volume":"49","author":"Flohil","year":"2013","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.jaad.2017.10.006_bib141","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2133.2009.09341.x","article-title":"Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"161","author":"Geng","year":"2009","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221732529X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221732529X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:45:40Z","timestamp":1759272340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221732529X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":141,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S019096221732529X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.10.006","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines of care for the management of basal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}